Skip to content

Study of comparative efficacy of Trisamagutika and Kshargutika in management of Tundikeri ( Chronic tonsillitis in children

Evaluation of comparative efficacy of Trisamagutika versus Kshargutika in management of (chronic tonsillitis) in children:A Randomized Clinical Study - Nil

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056542
Enrollment
72
Registered
2023-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B998- Other infectious disease

Interventions

None listed

Sponsors

Datta Meghe Institute of Higher Education and Researches Wardha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects presenting with two or more symptoms like 1. Kathin shoth(enlarged tonsils or lymph nodes) 2. Ragatwa(Hyperemia) 3.Galoprodh(difficulty in deglutination) 4. Mukhdourgandhya(halitosis) 5. Mand jwar (mild fever <100f)

Exclusion criteria

Exclusion criteria: 1. Tonsillar patients with peritonsillar abscess, tonsillar cyst and tonsillolith 2. Subjects with complications of tonsillitis as RHD, Rheumatic fever 3. Patients who had taken systemic steroids 4. Subjects with k/c/o HIV, TB, hepatitis-B and LRTI

Design outcomes

Primary

MeasureTime frame
Reduction in rate of recurrence of tonsillitis & significant results on parametersTimepoint: After 1 year follow up

Secondary

MeasureTime frame
effect on TLC, DLC, ESR, CRP, Kathin shoth, ragatwa, galoprodh, mukhdourgandhya, mand jwar & prakruti assessment will be doneTimepoint: At day 0, day 5 day 10 day 15 & haematological parameters at day 0 at day 15 at 6 months

Countries

India

Contacts

Public ContactDr Sonali Dhumale

Datta Meghe Institute of Higher Education and Research, Wardha

rbr.226@gmail.com9011058302

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026